Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2008
01/16/2008EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
01/16/2008EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
01/16/2008CN101107365A Simplified methods for isolating nucleic acids from cellular materials
01/16/2008CN101107352A Apparatus and system having dry gene silencing pools
01/16/2008CN101107262A Purification of oligonucleotides
01/16/2008CN101104632A Antisense oligonucleotide using apoptosis gene Caspase-4 as drone and use thereof
01/15/2008US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase
01/15/2008US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof
01/15/2008US7319144 Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay
01/15/2008US7319143 Genetically-engineered MHC molecules
01/15/2008US7319142 Nucleotide and amino acid sequences from Xenorhabdus and uses thereof
01/15/2008US7319141 Stem cell growth factor-like polypeptides
01/15/2008US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
01/15/2008US7319135 PRO1341 polypeptides
01/15/2008US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents
01/15/2008US7319087 Antimicrobial polypeptide from Aspergillus niger
01/15/2008US7319027 Contacting chiral primary amine, omega-transaminase, and amino acceptor to convert into ketone; stereospecific; gene expression; can be used to enrich enantiomerically a mixture of chiral amines or to synthesize stereoselectively one of a pair of chiral amines
01/15/2008US7319026 Amino acid-producing bacteria and a process for preparing L-amino acids
01/15/2008US7319024 C. elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of PAK activity in the nematode, caenorhabditis elegans
01/15/2008US7319023 Detection of hypermutable nucleic acid sequence in tissue
01/15/2008US7319021 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell
01/15/2008US7319013 Preparing a probe and screening genomic library or cDNA library of the species in question; or conducting computer search for analogous sequences in an electronic data base; expression cassettes; plant growth regulators
01/15/2008US7319008 Nucleic acid underexpressed in melanoma
01/15/2008US7319005 Primers and primer sets for use in methods to detect the presence of Acidovorax avenae subsp. citrulli
01/15/2008US7319003 Arrays of probes for positional sequencing by hybridization
01/15/2008US7318923 Humanized anti-βantibodies
01/15/2008US7318922 Anti-PRO5337 antibodies
01/15/2008US7318918 Interferon-alpha polypeptides and conjugates
01/15/2008CA2428319C Compositions and methods for diagnosing or treating psoriasis
01/15/2008CA2309556C Detection systems for registering protein interactions and functional relationships
01/15/2008CA2290768C Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
01/15/2008CA2251744C Methods for identifying predisposition to osteoarthritis by a vitamin d receptor genotype
01/15/2008CA2215176C C-nucleoside derivatives and their use in the detection of nucleic acids
01/11/2008CA2552493A1 Methods for producing interfering rnas
01/10/2008WO2008005019A1 Compositions and methods for the treatment of muscle wasting
01/10/2008WO2008005002A1 Compositions and methods for the treatment of muscle wasting
01/10/2008WO2007134181A3 5'-modified bicyclic nucleic acid analogs
01/10/2008WO2007044066A3 Methods for normalizing and for identifying small nucleic acids
01/10/2008WO2007027935A3 Cellular libraries of peptide sequences (clips) and methods of using the same
01/10/2008WO2003091400A3 Contraceptive targets
01/10/2008WO2002064744A3 Compositions and methods relating to colon specific genes and proteins
01/10/2008US20080010704 Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby
01/10/2008US20080010701 polynucleotides encoding polypeptides active in fructan, cellulose, starch and/or tannin biosynthetic pathways; transgenic plant cells
01/10/2008US20080010699 Lysophosphatidic acid acetyltransferases
01/10/2008US20080010698 Expansin Polypeptides
01/10/2008US20080010697 Methods of Expressing Heterologous Protein in Plant Seeds Using Monocot Non Seed-Storage Protein Promoters
01/10/2008US20080010693 Human coagulation factor VII polypeptides
01/10/2008US20080009614 Method for extracting nucleic acids
01/10/2008US20080009613 Determination of multiple nucleic acid sequences simultaneously; obtain sample, incubate with labeled probe, separate labeled nucleotide sequences, remove label, detect labels
01/10/2008US20080009612 Novel Polynucleotide Synthesis Labeling Chemistry
01/10/2008US20080009609 Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
01/10/2008US20080009551 Methods and Compositions for Identifying Modulators of G Protein-Coupled Receptors
01/10/2008US20080009463 Method of treating dry eye disease with purinergic receptor agonists
01/10/2008US20080009456 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation
01/10/2008US20080009455 Immunostimulatory oligonucleotides
01/10/2008US20080009454 Polynucleotide
01/10/2008US20080009446 Recombinant human albumin fusion proteins with long-lasting biological effects
01/10/2008US20080009444 Biologically active complex of NR6 and cardiotrophin-like-cytokine
01/10/2008US20080009066 Plant gene encoding trehalose metabolism enzymes
01/10/2008US20080009065 Genes encoding insect odorant receptors and uses thereof
01/10/2008US20080009060 Methods of discovering chemicals capable of functioning as gene expression modulators
01/10/2008US20080009056 Polypeptide, cDNA encoding the same and use of them
01/10/2008US20080009053 Modified Ethylenediamine-N, N'-Disuccinate: Ethylnediamine Lyase
01/10/2008US20080009052 a polypeptide having a higher catalytic activity for oxidation of cephalosporin C to glutaryl-7-aminocephalosporanic acid, than that of the wild-type polypeptide
01/10/2008US20080009036 DNA which encodes a protein that is capable of binding to 5'GGTACC-3'; producing recombinant Acc65I restriction endonuclease by culturing a host cell transformed with a vector containing the DNA
01/10/2008US20080009035 Culturing a host cell that includes a specific recombinant expression vector to produce reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs
01/10/2008US20080009033 Nucleic acid sequences encoding secretion-associated proteins; cells genetically manipulated to have an altered capacity to produce expressed proteins
01/10/2008US20080009032 Method for Producing Yellow Flower by Controlling Flavonoid Synthetic Pathway
01/10/2008US20080009012 Methods, libraries and computer program products for determining whether siRNA induced phenotypes are due to off-target effects
01/10/2008US20080009009 Device and method for high-throughput quantification of mRNA from whole blood
01/10/2008US20080009008 Composition and method for treating lupus nephritis
01/10/2008US20080009004 Claudin polypeptides, polynucleotides, and methods of making and use thereof
01/10/2008US20080009000 Using probes having priming sequence complementary to primer sequence, variable sequence and nucleotide; decoding microsphere array sensors
01/10/2008US20080008997 Proximity ligation assays with peptide conjugate 'burrs' and aptamers for the sensitive detection of spores and cancer cells
01/10/2008US20080008996 Nucleic acid molecules and other molecules associated with plants
01/10/2008US20080008993 Use Of A Type III Restriction Enzyme To Isolate Identification Tags Comprising More Than 25 Nucleotides
01/10/2008US20080008874 Matrix-assisted laser desorption ionization mass spectrometry substrates having low volume matrix array elements
01/10/2008US20080008718 Ornithobacterium Rhinotracheale Subunit Vaccines
01/10/2008US20080008713 Tumor Necrosis Factor Receptor I (TNFR1); immunoglobulins; competitive binding; inhibiting signal transduction; pharmacokinetics; storage stability
01/10/2008US20080008706 B7S1: an immune modulator
01/10/2008US20080008691 Modified growth hormone
01/10/2008US20080008690 AAV virions with decreased immunoreactivity and uses therefor
01/10/2008US20080008686 Tetracycline repressor regulated oncolytic viruses
01/10/2008US20080008684 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
01/10/2008US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins
01/10/2008US20080008680 pure mutant Interleukin-15 polypeptide; immunosuppressant; immunotherapy
01/10/2008US20080008650 Endometriosis cell targeting peptide and uses thereof
01/10/2008DE19528029B4 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use
01/10/2008DE10109466B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis
01/10/2008CA2662704A1 Rna silencing compositions and methods for the treatment of huntington's disease
01/10/2008CA2656525A1 Reversible terminator nucleotides and methods of use
01/10/2008CA2656315A1 Methods for fragmentation and labeling of nucleic acids
01/09/2008EP1874816A2 Modulation of antibody effector function by hinge domain engineering
01/09/2008EP1874810A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
01/09/2008EP1874804A2 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
01/09/2008EP1874794A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns
01/09/2008EP1874793A2 Delivery of sirna by neutral lipid compositions
01/09/2008EP1874792A1 Activators for oligonucleotide and phosphoramidite synthesis
01/09/2008EP1874791A1 Methods and compositions for regulated expression of nucleic acid at post-transcriptional level
01/09/2008EP1874790A2 New s-adenosyl-l-methionine analogs with extended activated groups for transfer by methyltransferases